- Home
- PRME vs INV Comparison
PRME vs INV Comparison
Compare PRME & INV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- INV
- Stock Information
- Founded
- PRME 2019
- INV 2015
- Country
- PRME United States
- INV United States
- Employees
- PRME N/A
- INV N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- INV
- Sector
- PRME Health Care
- INV
- Exchange
- PRME Nasdaq
- INV NYSE
- Market Cap
- PRME 191.7M
- INV 173.3M
- IPO Year
- PRME 2022
- INV N/A
- Fundamental
- Price
- PRME $4.21
- INV $5.00
- Analyst Decision
- PRME Buy
- INV Strong Buy
- Analyst Count
- PRME 6
- INV 2
- Target Price
- PRME $9.38
- INV $14.00
- AVG Volume (30 Days)
- PRME 5.8M
- INV 84.8K
- Earning Date
- PRME 08-08-2025
- INV 08-15-2025
- Dividend Yield
- PRME N/A
- INV N/A
- EPS Growth
- PRME N/A
- INV N/A
- EPS
- PRME N/A
- INV N/A
- Revenue
- PRME $3,846,000.00
- INV $1,220,000.00
- Revenue This Year
- PRME $104.12
- INV $1,045.66
- Revenue Next Year
- PRME $108.24
- INV $240.46
- P/E Ratio
- PRME N/A
- INV N/A
- Revenue Growth
- PRME 550.76
- INV 18.27
- 52 Week Low
- PRME $1.11
- INV $3.00
- 52 Week High
- PRME $5.95
- INV $18.75
- Technical
- Relative Strength Index (RSI)
- PRME 60.42
- INV N/A
- Support Level
- PRME $3.71
- INV N/A
- Resistance Level
- PRME $5.15
- INV N/A
- Average True Range (ATR)
- PRME 0.53
- INV 0.00
- MACD
- PRME -0.06
- INV 0.00
- Stochastic Oscillator
- PRME 34.25
- INV 0.00
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.